Home > Compound List > Product Information
Aminophylline_Molecular_structure_CAS_317-34-0)
Click picture or here to close

Aminophylline

Catalog No. DB01223 Name DrugBank
CAS Number 317-34-0 Website http://www.ualberta.ca/
M. F. C16H24N10O4 Telephone (780) 492-3111
M. W. 420.42636 Fax (780) 492-1071
Purity Email david.wishart@ualberta.ca
Storage Chembase ID: 1093

SYNONYMS

IUPAC name
bis(1,3-dimethyl-2,3,6,7-tetrahydro-1H-purine-2,6-dione); ethane-1,2-diamine
IUPAC Traditional name
ethylenediamine; bis(theophylline)
Brand Name
Theolone
Somophyllin O
Rectalad-Aminophylline
Diuxanthine
Aminodur
Cardiomin
Cardophyllin
Diaphylline
Etilen-Xantisan Tabl.
Genophyllin
Methophylline
Phylcardin
Rectalad Aminophylline
Somophyllin
Theophyllin Ethylenediamine
Variaphylline
Aminocardol
Ammophyllin
Cardiofilina
Cardophylin
Diophllin
Dobo
Dura-Tab S.M. Aminophylline
Ethophylline
Eurphyllin
Euufillin
Grifomin
Lasodex
Metaphyllin
Norofilina
Phyllindon
Theolamine
Theophyldine
Theophyllamine
Theophyllin Aethylendiamin
Theophylline Ethylenediamine
Truphylline
Vasofilina
Carena
Cariomin
Inophylline
Linampheta
Lixaminol
Metaphylline
Minaphil
Miofilin
Neophyiline
Peterphyllin
Phyllocontin
Phyllocontin-350
Somophyllin-O
Stenovasan
Syntophyllin
Theodrox
Theophyline Ethylenediamine
Theophyllaminum
Thephyldine
Synonyms
Aminophylline Anhydrous
Aminophyllin
Aminophylline Dihydrate
Aminophylline Dye Free

DATABASE IDS

PubChem SID 46508784
PubChem CID 9433
CAS Number 317-34-0

PROPERTIES

Hydrophobicity(logP) -3.03
Solubility 2E+005 mg/L

DETAILS

Description (English)
Item Information
Drug Groups approved
Description Aminophylline is a drug combination that contains theophylline and ethylenediamine in 2:1 ratio. [Wikipedia]
Indication For the treatment of bronchospasm due to asthma, emphysema and chronic bronchitis.
Pharmacology Aminophylline is the ethylenediamine salt of theophylline. Theophylline stimulates the CNS, skeletal muscles, and cardiac muscle. It relaxes certain smooth muscles in the bronchi through PDE3 inhibition, produces diuresis, and causes an increase in gastric secretion.
Affected Organisms
Humans and other mammals
Half Life 7-9 hours
Protein Binding 60%
Distribution * 0.3 to 0.7 L/kg
Clearance * 0.29 mL/kg/min [postnatal age 3-15 days]
* 0.64 mL/kg/min [postnatal age 25-57 days]
* 1.7 mL/kg/min [?1-4 years]
* 1.6 mL/kg/min [4-12 years]
* 0.9 mL/kg/min [13-15 years]
* 1.4 mL/kg/min [16-17 years]
* 0.65 mL/kg/min [Adults (16-60 years), non-smoking asthmatics]
* 0.41 mL/kg/min [Elderly (>60 years). liver, and renal function]
* 0.33 mL/kg/min [Acute pulmonary edema]
* 0.54 mL/kg/min [COPD->60 years, stable non-smoker >1 year]
* 0.48 mL/kg/min [COPD with cor pulmonale]
* 1.25 mL/kg/min [Cystic fibrosis (14-28 years)]
* 0.31 mL/kg/min [Liver disease -cholestasis]
* 0.35 mL/kg/min [cirrhosis]
* 0.65 mL/kg/min [acute hepatitis]
* 0.47 mL/kg/min [Sepsis with multi-organ failure]
* 0.38 mL/kg/min [hypothyroid]
* 0.8 mL/kg/min [hyperthyroid]
External Links
Wikipedia
Drugs.com

REFERENCES